Sorry, you need to enable JavaScript to visit this website.

Competitive Grants Program

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Optimizing Antimicrobial Stewardship (AMS) Interventions and Outcomes in Clinical Outcomes, Optimal Use and Resource Utilizatio
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology China
    Optimizing Disease Management to Improve Alopecia Areata Quality of Care
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Inflammation & Immunology China
    Research on Exploring Disease Assessment and Prioritizing Systematic Treatment for Vitiligo
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology China
    Quality Improvement in Molecular Testing Pathways for Metastatic Colorectal Cancer (mCRC)
    Release Date:
    Partner: American Society for Clinical Pathology (ASCP)
    Review Process: Expert Review Panel
    Quality Improvement Oncology USA
    Personalized monitoring&treatment for HR+, HER2- mBC patients treated w CDK4/6i: incorporating Patient complexity risk factors
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement, Research Oncology Italy
    Providing Appropriate Medical Care for IBD Patients
    Release Date:
    Partner: Japanese Society for Inflammatory Bowel Disease (JSIBD)
    Review Process: Expert Review Panel
    Translation: Japanese (link)
    Quality Improvement Inflammation & Immunology Japan
    Administration of brentuximab vedotin alone or in combination with other approved agents in pre and/or peri CAR-T
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology USA
    Fostering Educational Initiatives for ALK+ Metastatic Non-Small Cell Lung Cancer(mNSCLC) Tyrosine Kinase Inhibitors(TKI) Therapy
    Release Date:
    Review Process: Pfizer Internal
    Translation: French (link)
    Education Oncology Canada
    2026 Inflammatory Bowel Disease (IBD) Fellowship- United States
    Release Date:
    Review Process: Expert Review Panel
    Fellowship Inflammation & Immunology USA
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Multidisciplinary Team Education in Duchenne Muscular Dystrophy (see RFP for specific geographic scope)
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease All
    2023/2024 Global NASH ASPIRE
    Release Date:
    Review Process: Expert Review Panel
    Research Internal Medicine All
    Improving Metastatic Breast Cancer (mBC) Quality of Care and Equity via Meaningful Capacity Building in South East Asia
    Release Date:
    Partner: Conquer Cancer®, the ASCO Foundation
    Review Process: Expert Review Panel
    Quality Improvement Oncology Hong Kong, Indonesia, Malaysia, Myanmar, Papua New Guinea, Philippines, Singapore, Solomon Islands, Taiwan, Thailand, Vietnam
    Alopecia Areata Education for Pediatric Dermatologists, Dermatologists, and Advanced Practice Providers
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Implementation of Revised USP <797> Pharmaceutical Compounding-Sterile Preparations: Challenges and Opportunities
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital USA
    Improving Care for Patients with Multiple Myeloma
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    HRRm Testing in Metastatic Prostate Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Advancing Oncology Education for Healthcare Professionals
    Release Date:
    Review Process: Pfizer Internal
    Translation: French (link)
    Education Oncology Benin, Burkina Faso, Burundi, Cameroon, Central African Republic, Chad, Comoros, Congo, Congo, The Democratic Republic, Cote D'ivoire, Djibouti, Gabon, Guinea, Madagascar, Mali, Niger, Rwanda, Senegal, Seychelles, Togo
    Providing Appropriate Medical Care for IBD Patients
    Release Date:
    Partner: Japanese Society for Inflammatory Bowel Disease (JSIBD)
    Review Process: Expert Review Panel
    Quality Improvement Inflammation & Immunology Japan
    Real World Evidence of Abrocitinib in Patients with Moderate-to-Severe Atopic Dermatitis
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology All
    Addressing Gaps in Care for Patients with Multiple Myeloma (Europe)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Improving Breast Cancer (BC) Quality of Care via Meaningful Capacity Building in Sub-Saharan Africa
    Release Date:
    Partner: Conquer Cancer®, the ASCO Foundation
    Review Process: Expert Review Panel
    Translation: French (link)
    Translation: Portuguese (link)
    Quality Improvement Oncology Congo, The Democratic Republic, Ethiopia, Ghana, Malawi, Mali, Mozambique, Rwanda, Senegal, Tanzania, United Republic of, Uganda, Zambia, Zimbabwe